Key result
Although PA28α/β modulates antigen processing and viral replication in vitro, genetic ablation of PA28α/β in mice had no significant impact on disease progression during coxsackievirus B3 myocarditis.
While PA28α/β modulates antigen processing and viral replication in vitro during CVB3 infection, it is dispensable for disease progression in a resistant mouse model of viral myocarditis.
Answers are grounded in this paper and cite their sources.
PA28β upregulation in viral myocarditis is hypothesis-generating; leaves open its role in immunoproteasome function.
The function of the proteasome is modulated at the level of subunit expression and by association with its regulatory complexes. During coxsackievirus B3 (CVB3) myocarditis, IFN-induced formation of immunoproteasomes (ip) is known to be critical for regulating immune modulating molecules. The function of the IFN-γ-inducible proteasome regulator subunits PA28 α and β, however, in this context was unknown. During viral myocarditis, we found an increased abundance of PA28β subunits in heart tissue. PA28α/β exists in PA28-20S-PA28 and PA700-20S-PA28 hybrid proteasome complexes in cells both with either predominant ip and standard proteasome (sp) expression. Being in line with reduced proteasome activity in PA28α/β-deficient cells, we observed increased levels of oxidized and poly-ubiquitinated proteins upon TLR3-activation in these cells. Moreover, PA28α/β is capable to interfere directly with viral replication of CVB3 and facilitates the generation of CVB3-derived MHC class I epitopes by the proteasome. In contrast to a distinct function of PA28α/β in vitro, gene ablation of PA28α/β in mice being on a genetic background with resistance towards the development of severe infection had no significant impact on disease progression. Other than reported for the ip, in this host PA28α/β is dispensable to meet the demand of increased peptide hydrolysis capacity by the proteasome during viral myocarditis.
No takes yet. Share an insight, caveat, or question.
Respondek et al. (2017) studied Coxsackievirus B3 (CVB3) infection / viral myocarditis (n=35). PA28α/β gene ablation vs. Wild-type (PA28α/β+/+) was evaluated on Disease progression (myocardial lesions, viral titers, weight loss). Although PA28α/β modulates antigen processing and viral replication in vitro, genetic ablation of PA28α/β in mice had no significant impact on disease progression during coxsackievirus B3 myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: